200 related articles for article (PubMed ID: 9695963)
1. Patients with high-risk myelodysplastic syndrome can have polyclonal or clonal haemopoiesis in complete haematological remission.
Delforge M; Demuynck H; Verhoef G; Vandenberghe P; Zachée P; Maertens J; Van Duppen V; Boogaerts MA
Br J Haematol; 1998 Jul; 102(2):486-94. PubMed ID: 9695963
[TBL] [Abstract][Full Text] [Related]
2. Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene.
van Kamp H; Fibbe WE; Jansen RP; van der Keur M; de Graaff E; Willemze R; Landegent JE
Blood; 1992 Oct; 80(7):1774-80. PubMed ID: 1356510
[TBL] [Abstract][Full Text] [Related]
3. Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms.
Tsukamoto N; Morita K; Maehara T; Okamoto K; Karasawa M; Omine M; Naruse T
Br J Haematol; 1993 Apr; 83(4):589-94. PubMed ID: 8100140
[TBL] [Abstract][Full Text] [Related]
4. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin.
Janssen JW; Buschle M; Layton M; Drexler HG; Lyons J; van den Berghe H; Heimpel H; Kubanek B; Kleihauer E; Mufti GJ
Blood; 1989 Jan; 73(1):248-54. PubMed ID: 2562924
[TBL] [Abstract][Full Text] [Related]
5. Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromes.
Guidetti F; Grazioli S; Capelli F; Marini C; Gallicchio M; De Micheli D; Castello L; Sainaghi PP; Fra GP; Saglio G; Avanzi GC
Haematologica; 2004 Jan; 89(1):21-8. PubMed ID: 14754602
[TBL] [Abstract][Full Text] [Related]
6. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
7. Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes.
Delforge M; Demuynck H; Vandenberghe P; Verhoef G; Zachée P; van Duppen V; Marijnen P; Van den Berghe H; Boogaerts MA
Blood; 1995 Nov; 86(10):3660-7. PubMed ID: 7579331
[TBL] [Abstract][Full Text] [Related]
8. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
[TBL] [Abstract][Full Text] [Related]
9. Long-term remission after intensive chemotherapy in advanced myelodysplastic syndromes is generally associated with restoration of polyclonal haemopoiesis.
Aivado M; Rong A; Germing U; Gattermann N; Kobbe G; Rieth C; Haas R; Aul C
Br J Haematol; 2000 Sep; 110(4):884-6. PubMed ID: 11054075
[TBL] [Abstract][Full Text] [Related]
10. Clonal remissions in acute myeloid leukaemia are commonly associated with features of trilineage myelodysplasia during remission.
Jowitt SN; Liu Yin JA; Saunders MJ; Lucas GS
Br J Haematol; 1993 Dec; 85(4):698-705. PubMed ID: 7918032
[TBL] [Abstract][Full Text] [Related]
11. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
[TBL] [Abstract][Full Text] [Related]
12. [Cell clonality in myelodysplastic syndrome].
Krejcová H; Neuwirtová R; Cermák J; Belicková M; Brdicka R
Sb Lek; 2002; 103(3):339-48. PubMed ID: 12688178
[TBL] [Abstract][Full Text] [Related]
13. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
[TBL] [Abstract][Full Text] [Related]
15. Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro.
Bouscary D; Chen YL; Guesnu M; Picard F; Viguier F; Lacombe C; Dreyfus F; Fontenay-Roupie M
Exp Hematol; 2000 Jul; 28(7):784-91. PubMed ID: 10907640
[TBL] [Abstract][Full Text] [Related]
16. Maturation-associated immunophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes.
Ribeiro E; Matarraz Sudón S; de Santiago M; Lima CS; Metze K; Giralt M; Saad ST; de Matos AO; Lorand-Metze I
Leuk Res; 2006 Jan; 30(1):9-16. PubMed ID: 16005514
[TBL] [Abstract][Full Text] [Related]
17. Clonal analysis of peripheral blood and haemopoietic colonies in patients with aplastic anaemia and refractory anaemia using the polymorphic short tandem repeat on the human androgen-receptor (HUMARA) gene.
Anan K; Ito M; Misawa M; Ohe Y; Kai S; Kohsaki M; Hara H
Br J Haematol; 1995 Apr; 89(4):838-44. PubMed ID: 7772520
[TBL] [Abstract][Full Text] [Related]
18. Clonality analysis of refractory anemia with ring sideroblasts: simultaneous study of clonality and cytochemistry of bone marrow progenitors.
Suzuki H; Asano H; Ohashi H; Kinoshita T; Murate T; Saito H; Hotta T
Leukemia; 1999 Jan; 13(1):130-4. PubMed ID: 10049048
[TBL] [Abstract][Full Text] [Related]
19. Apparent expansion of CD34+ cells during the evolution of myelodysplastic syndromes to acute myeloid leukemia.
Span LF; Dar SE; Shetty V; Mundle SD; Broady-Robinson L; Alvi S; Raymakers RA; de Witte T; Raza A
Leukemia; 1998 Nov; 12(11):1685-95. PubMed ID: 9823942
[TBL] [Abstract][Full Text] [Related]
20. Amifostine does not preferentially stimulate the growth of residual polyclonal progenitor cells in myelodysplastic syndromes.
Delforge M; Raets V; Van Duppen V; Boogaerts M
Leuk Res; 2003 Jul; 27(7):593-8. PubMed ID: 12681358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]